Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide-Reference-Cited by-同舟云学术

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

Published:1999-06 Issue:6 Volume:29 Page:1690-1697
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Angeli Paolo,Volpin Roberta,Gerunda Giorgio,Craighero Raffaella,Roner Paola,Merenda Roberto,Amodio Piero,Sticca Antonietta,Caregaro Lorenza,Maffei-Faccioli Alvise,Gatta Angelo

Publisher

Wiley

Subject

Hepatology

Reference48 articles.

1. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

2. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis

3. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis

4. Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2in cirrhosis. Relationship to functional renal failure and sodium and water excretion

5. Plasma Endothelin Immunoreactivity in Liver Disease and the Hepatorenal Syndrome

Cited by 465 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Octreotide Causing Hyperkalemia: A Case Report and Review of the Literature;Cureus;2024-08-30

2. Effects of Transjugular Intrahepatic Portosystemic Shunt on Renal and Pulmonary Function in Hepatic Decompensation with and without Hepatorenal and Hepatopulmonary Syndromes: A Review;Journal of Clinical and Translational Hepatology;2024-07-25

3. Hepatorenal Syndrome in Cirrhosis;Gastroenterology;2024-04

4. Management of hepatorenal syndrome and associated outcomes: a systematic review;BMJ Open Gastroenterology;2024-04

5. Pathophysiology of Hepatorenal Syndrome;Advances in Kidney Disease and Health;2024-03